7.55 (0.01%)
As of Jan 14, 2022
Source:
We are an ophthalmic pharmaceutical company focused on the discovery, development and commercialization offirst-in-classtherapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases.
| Country | United States |
| Headquarters | durham, north carolina |
| Phone Number | (919) 237-5300 |
| Industry | manufacturing |
| CEO | Raj Kannan |
| Website | aeriepharma.com |